chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; his body is cold; This is a spontaneous report from a contactable consumer (patient himself). A 48-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0179, Expiry date: not reported), via an unspecified route of administration on 08May2021 (48-year-old at vaccination) as Dose 2, Single for COVID-19 immunization. There was no relevant medical history reported. The patient's concomitant medication included paracetamol (TYLENOL) (patient had taken it for fever).The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EW0164, Expiry date: not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient experienced fever on 10May2021 and was ongoing at time of report and he though this may go away tomorrow. On an unspecified date in 2021 his body was cold. The reporter wanted to know if the fever experienced was normal or associated with vaccine. The patient confirmed he took Tylenol today for the fever as he was experiencing after the vaccine. No investigation assessment was reported. The outcome of the event fever was not recovered and unknown for other event.   No follow-up attempts are needed. No further information is expected.
12 hours after injection: chills, fever started to elevate.  14-16 hours after =102° fever, fatigue, joint aches. Swollen lymph node in infected arm.    Fever started to drop after 48 hours.   Lymph node pain, joint pain, fatigue persists 3 days later.
LEFT ARM PAIN AT INJECTION SITE AND UNDER ARM. INCLUDED CHEST AREA WHICH FEELS TIGHT.
once medical records were sent, unable to open them; pt had a positive COVID test on 11/24/21; per death certificate pt died in the ED with Respiratory Arrest due to COVID 19 and COVID 19 being the causes of death
On Oct. 12, stores received an internal Urgent Removal Notice regarding Pfizer COVID-19 Vaccine- Pediatric 5-11 Years Tris-sucrose, Lot #FL2757 with manufacturer?s expiration date of Sept. 30. Information has been received from the manufacturer indicating that stability data supports the use of this product through Oct. 19.  What I need to do:  Administration data from Agency indicates your location administered doses of the affected lot after the Sept. 30 expiration date but on or before Oct. 19. For doses administered between Oct. 1 and Oct. 19, with manufacturer data to support the stability and efficacy, revaccination is not indicated, and patient notification is not required. Any dose administered on or after Oct. 1 must be reported in database and VAERS.
stiffness in arm; he had pfizer vaccine and had soreness at site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 21K-163-4210732-00.  A 57-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 55 years intramuscular for covid-19 immunisation. The patient's relevant medical history included: "psoriatic arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Route of Administration: Intramuscular), administration date: 15Mar2021, when the patient was 55-year-old, for COVID-19 Immunization, reaction(s): "Shoulder soreness/ soreness in shoulder", "covid vaccination site soreness", "stiffness in arm". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "he had pfizer vaccine and had soreness at site"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 2021, outcome "unknown", described as "stiffness in arm".  Additional Information: The reaction onset date was in 2021. The patient did not have pain in hands and wrists. The patient's Psoriatic arthritis had improved since skyrizi and had sore muscles from over use.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
At 3:10 pm, 10 minutes after vaccine given, patient began experiencing itching and lip tingling. Vital signs were taken patient BP was 220/120, pulse 86 and oxygen sat was 98% on room  air.  Paramedics was called, patient began experiencing full body itching and became hoarse and began clearing her throat, face became flushed, vitals taken again and BP was 210/120 and O2 was 98 %. Paramedics arrived at 3:18 and IV was started, patient was given 50mg benadryl IV push and transported to hospital
This non serious case was received on 24 February 2009 from VAERS (reference number 329987) via a search of the QSCAN database. A 39 year old female received FLUZONE SV 2008-2009 (lot number U2740AA) intramuscular on 15 October 2008. One hour post vaccination the patient developed heaviness in the arm which was injected, redness, swelling, discharge, and itching in her eyes, fever, fatigue and head pressure. The patient was reported as recovered. No further information was received. List of Documents held by Sender: none.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The health care professional (HCP) wanted to know what the protocol was for this situation and if the doses were viable or not. The nurse had not the whole information for the 606 doses so they would gather everything in a spreadsheet (including patient information). HCP said that there was a confusion between the expiration date printed in the carton and the expiration date when the quick response code was scanned. It was reported that the nurse wanted to know if Moderna had the following lot number 041C21A.There was no product complaint associated. No treatment medications were reported.
Chief Complaint   Pt tested positive for covid 08/06, c/o worsening SOA, fever tmax 102, headache, body aches, N/V/D, sore throat. Spo2 89% RA, 93% on 2L NC, T: 39.4. Received first dose of covid vaccine 2 weeks ago.
the patient did end up getting covid virus in 2022; the patient did end up getting covid virus in 2022; The initial case was missing the following minimum criteria: adverse event and suspect drug (unspecified). Upon receipt of follow-up information on 13Nov2023, this case now contains all required information to be considered valid.   This is a spontaneous report received from a contactable reporter(s) (Consumer) from product quality group, Program ID:. The reporter is the parent. A 23-year-old male patient received bnt162b2 (BNT162B2), on 09Dec2021 as dose 3 (booster), single (Lot number: 33030BD) at the age of 21 years for covid-19 immunization. The patient's relevant medical history included: "dialysis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: PFIZER covid vaccine (Dose 1, Lot: EN9581), administration date: 24Feb2021, when the patient was 21-year-old, for COVID-19 immunization; PFIZER covid vaccine (Dose 2, Lot: EP7534), administration date: 17Mar2021, when the patient was 21-year-old, for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "the patient did end up getting covid virus in 2022".
First, I had moderate pain in my right arm and near the injection site. After the first dose, my right arm and hand became numb with loss of feeling or touch. This lasted for most of the evening, about 12 hours after vaccination. The injection site and the muscle were in a lot of pain, which climbed up into my neck muscle. I did not have any fever or chills. For the past several days, I have become fatigued very easily. Lastly, my lower abdominal area has become sore with discomfort. I have never experienced this before, and I am not currently menstruating either. Tylenol makes it better, and resting on my back and excess movement makes it worse.
Client showed Case Manager photos of red circular rash spots covering client's arm which were reportedly taken approximately 3 days after the MPOX injection was administered by the Department of Health and Environment nurse.
Pt had a diffuse rash on his face, trunk and extremities. MOC was instructed by clinic MA to give pt 2.5 mL of Benadryl. MOC gave pt the Benadryl, and the rash improved slightly. Pt also had a temperatre of ~101 at home. MOC denies that pt has been exposed to any new soaps, detergents, parental colognes/perfumes, plants, animals, or foods.
Local swelling, redness, tenderness at injection site with diffuse aches and fever 101. 1 day after shots in a.m. pt had extreme pain in (R) deltoid radiating down tricep under arm around to pec muscle. Pt states pain was gone by noon on 9/26/10 pt took TYLENOL 500-1000mg Q 6 hours for fever reducement.
My throat at first starting feeling weird and I realized my throat was starting to close.  It then started to feel hard to swallow.  I took a Benadryl since I have experienced this in the past if it does not get better within an hour I will go to urgent care.
Fever up to 103.2 started 2/4/16 after immunizations were given. Rash on inner thighs and behind knees started today.
Soreness/pain in the injection site starting 3pm on January 8, 2021 until January 10 at 11am. I cannot lift the affected arm but still can do light activities like eating, writing, typing, etc. Chills and fatigue starts saturday January 9 at 7pm until January 10 at 11pm. I took tylenol starting January 8 for the pain until pain is gone and took Theraflu starting January 9 until sunday bedtime at 11pm. Bedrest and increase fluid intake one of the interventions, besides medicines.
MANY HIDRADENITIS SUPPURATIVA FLARE UPS; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe hidradenitis suppurativa. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on JUN-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number: UNKNOWN expiry: UNKNOWN) dose, frequency, and therapy dates were not reported for moderate to severe hidradenitis suppurativa. No concomitant medications were reported. On an unspecified date, the patient experienced many hidradenitis suppurativa flare ups. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The patient was recovering from many hidradenitis suppurativa flare ups. This report was non-serious.
High fever of 102.8; Chills; Aches; Swollen lymph nodes under arm ofshot; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 09:00 as a single dose (at the age of 41-years-old) for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to penicillin. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration in the left arm on 01Mar2021 at 09:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 21:00, the patient had experienced, high fever of (102.8), chills, aches and had swollen lymph node under arm of shot. Th patient did not receive treatment for the reported events. The clinical outcome of the events high fever of 102.8, chills, aches and swollen lymph node under arm of shot was resolved on an unspecified date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Egg sized swelling at site of varicella shot. Began next morning/discolored. Advised to come in but declined.
Co health center did not see client after adm of Tdap. School nurse contacted health center stating student had app 1/2: wide and 3 1/2" long faint but visible red area, streak from injection site. Health center called mom and ref. pt to her local doctor. Follow up calls to the home. Left message with pt for her mom to call health center. No response from parent. Pt stated they saw Dr. and no RX was made.
Pediatric dose administered to adult; Pediatric dose administered to adult; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 39-year-old female patient who received HBV (Engerix B pediatric) (batch number L9Y4G, expiry date 5th April 2024) for prophylaxis.   On 21st November 2022, the patient received Engerix B pediatric. On 21st November 2022, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK receipt date: 21-Nov-2022 Reporter's comment: A pharmacist called to asked for information about the administration of a pediatric dose of Engerix-B to a patient. The reporter asked if they could administer an extra pediatric dose in order to complete a full adult dose of Engerix-B. The reporter consented to follow-up. Additional supportive information: The patient received a pediatric dose of Engerix-B, which led to underdose and adult use of a child product.
tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 10Apr2021 (Lot number: EW0151) at the age of 64 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: IBUPROFEN. Vaccination history included: Bnt162b2 (Dose 1, Single, product COVID 19, brand Pfizer, lot number EP7534,), administration date: 20Mar2021, when the patient was 64 years old, for COVID-19 immunization, reaction(s): "No issues w/1st dose".  The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "tiredness".  Additional information: No issues w/1st dose, tiredness the day following 2nd dose.  No follow-up attempts are possible. No further information is expected.
i am having frequent heart palpitations. This happened after the first booster. They lasted about 2 months and then disappeared
Information has been received concerning a pt who was vaccinated on 02/11/97 was vaccinated with the first dose of varicella. On 06/18/00 the pt developed a rash on body on the left side at approximately T10 dermatosis-herpes zoster at the level of umbilicus.
her arm really  blew up after the first dose, states there was a firm bump at the injection site.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EW167) as dose 1, single for covid-19 immunisation. Relevant medical history included: "autoimmune anticardioid lipid" (ongoing). Concomitant medication(s) included: WARFARIN DEANOL. The following information was reported: VACCINATION SITE MASS (non-serious), outcome "unknown", described as "her arm really  blew up after the first dose, states there was a firm bump at the injection site.". Additional information: Caller states her arm really blew up after the first dose, states there was a firm bump at the injection site. The patient was taking concomitant product Warfarin for blood clots. Dosage text: 5mg 2 days a week and 7.5mg the other 5 days a week, tablets. No investigation assessment. Caller stated she got the second dose of the Pfizer Covid vaccine today, 19May2021, and while she was waiting for her 15 minutes, her vision became blurry, states they kept her there, caller states it was not going away, not sure what to do, had not heard of this before, wanted information about this symptom. Caller asks if she could be told how to treat it.   Follow-up attempts completed. No further information expected.
Pfizer-BioNTech COVID-19 Vaccine EUA: shortly after vaccination patient reported itching at injection site and in throat. Initial vital signs within normal ranges except pulse 100-110 beats per minute and blood pressure 180/90 mmHg. Patient administered diphenhydramine 25 mg orally and transported to the emergency department. On arrival and during physical exam patient noted to have red "splochyness" on chest wall but no hives. Patient awake, alert, oriented: no shortness of breath, stridor, or oral or pharyngeal swelling. Patient observed, symptoms improved, vital signs stable, and discharged to home.
I experienced normal side effects. Aches, fever, headache, chills, fever for about 5 days. They subsided, but I still don?t have an appetite, and I keep coughing up mucous, some with what looks like blood streaks, like a blood vessel, and blood spots when I blow my nose. And my lungs feel heavy. And it?s almost impossible to breathe deeply with coughing. Although I can go a few hours without coughing. The blood is very rare but it has happened several times in the past 4-5 days. It could have to do with my vaping, but it isn?t normal, only since being vaccined.
In August 2021 I first noticed symptom of apparent PAC with pause and augmented next beat, frequently every minute.  EKG confirmed. I had no other symptoms, specifically, never any symptoms of myocarditis or pericarditis after either of the first two vaccinations (Jan-Feb 2021).  It is possible I had COVID March-April 2020 after spending a weekend managing a large inpatient service with patients in three ICUs, but I was never tested.  In August-Oct 2021, I had additional EKG and workup including respiratory panel that identified only RSV (asymptomatic), 5-day Holter monitor that identified 10% PACs and two short runs of several seconds of SVT, and a few PVCs and subsequently had a nuclear medicine treadmill stress test, on which I exceeded age-specific predicted maximum HR and held HR for extended period with no symptoms and no arrhythmia with elevated HR.  CO remained normal, as were nuclear medicine perfusion and wall motion and EF.  My resting HR is in the mid 50s and that is when the PACs are most noticeable.  With elevation in HR, I do not sense PACs.  I have had 3 subsequent vaccinations: Pfizer boost 11/09/2021, Moderna boost 7/26/2022 and Moderna bivalent 11/05/2022, all with no adverse effect.  I do not know if my development of frequent PACs is associated with vaccination or not.  My arrhythmia remains unchanged and I have no prescription treatment for it.  I asked my cardiologist if I just have an ectopic atrial irritable focus that fires when my HR falls below X and he said yes.
Since administered vaccines below eyes started "crossing". Fevers also. Fatigued. Both eyes "drift".
Right testicle and perineal pain, fever/chills, myalgias, h/a.
Tingling in right cheek, along with a headache, about an hour after receiving vaccine. This was followed by a sensation of muscle weakness. The injection site also had a red square around it that was elevated for over four days?on top of a swollen shoulder. As of 5/6/2021 (a day after my second dose), the mild facial weakness has not subsided.  Furthermore, exactly 7 days after the first vaccine was administered, I visited urgent care due to pain, redness, and swelling returning to the injection site in addition to the site becoming warm. That dissipated within a day or two.
This is a spontaneous report from a Pfizer-sponsored program Pfizer RxPathways via a contactable consumer reported for herself. A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 15Apr2021 (Batch/Lot number was not reported) at the age of 56-year-old, as single dose for covid-19 immunization. Medical history included back surgeries, reported she had a history of back surgeries in the past all of which she recovered well from and mild osteoarthritis in the past. The patient's concomitant medications were not reported. The patient received the historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on an unspecified date for Covid-19 immunization. On an unspecified date in 2021, she seemed to be having an ongoing reaction to the vaccine resulting in edema, parasthesia and severe joint pain. She was concerned at this point and would like to know how long it can take for the inflammation in her body to subside. She was extremely healthy and fit and have never experienced anything like this. Caller was calling about the covid vaccine. She was having long term reactions. She had seen several doctors, internist, vascular doctor, neurologist, and orthopedist. Her symptoms were severe joint swelling and pain in her knees and thumbs, she had mild osteoarthritis, paresthesia, neuropathy and severe edema. She is an armature athlete. She was scared because her symptoms were not going away. She wanted to do more than reporting bad side effects she would like to speak to someone to see if there are any other people reporting this. Within a couple weeks began to experience the following symptoms: severe inflammation and joint pain, pain in knees and thumbs, mild osteoarthritis in the past that was now severely inflamed, paresthesia described as pins and needles, neuropathy in the hands and feet falling asleep, burning sensation, severe edema, and lymphedema in the legs. Caller reported she was still experiencing the pain right now and it felt like her knee and thumb joints are on fire. Caller had sought medical care from the orthopedic, vascular, and neurologist. They had checked for DVT and autoimmune diseases. Caller was seeking information if other patients have reported these long lasting symptoms. The outcome of the event severe edema, paresthesia described as pins and needles, severe joint pain was not recovered. The outcome of the other events was unknown. Information on the batch/lot number has been requested.
approx 6 hrs p/vax was noted on pt's rt thigh to above knee area was red, warm, extremly tender to touch; area was also edematous; bruising size of quarter around puncture; no temp; dx as topical rxn to pertussis;